FR2128467A1 - Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen - Google Patents
Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigenInfo
- Publication number
- FR2128467A1 FR2128467A1 FR7207042A FR7207042A FR2128467A1 FR 2128467 A1 FR2128467 A1 FR 2128467A1 FR 7207042 A FR7207042 A FR 7207042A FR 7207042 A FR7207042 A FR 7207042A FR 2128467 A1 FR2128467 A1 FR 2128467A1
- Authority
- FR
- France
- Prior art keywords
- sulphate
- antigen
- agents
- polymers
- contg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 239000003795 chemical substances by application Substances 0.000 title abstract 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 title abstract 3
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 6
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 229920002567 Chondroitin Polymers 0.000 abstract 1
- 229920002307 Dextran Polymers 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108010074605 gamma-Globulins Proteins 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
- 239000001117 sulphuric acid Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712110488 DE2110488A1 (de) | 1971-03-02 | 1971-03-02 | Mittel zur Induzierung einer fruehzeitigen,langanhaltenden und erhoehten Immunitaet sowie Verfahren zur Induzierung der Antikoerperbildung durch Verwendung dieses Mittels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2128467A1 true FR2128467A1 (en) | 1972-10-20 |
| FR2128467B1 FR2128467B1 (enExample) | 1975-02-07 |
Family
ID=5800577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7207042A Granted FR2128467A1 (en) | 1971-03-02 | 1972-03-01 | Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT312801B (enExample) |
| BE (1) | BE780131A (enExample) |
| DE (1) | DE2110488A1 (enExample) |
| ES (1) | ES400162A1 (enExample) |
| FR (1) | FR2128467A1 (enExample) |
| IL (1) | IL38861A0 (enExample) |
| NL (1) | NL7202806A (enExample) |
| ZA (1) | ZA721224B (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995002688A1 (en) * | 1993-07-16 | 1995-01-26 | Chiron Viagene, Inc. | Methods and compositions for the removal of viruses and uses thereof |
| WO2001049320A3 (en) * | 2000-01-05 | 2002-01-17 | Cambridge Biopolymers Ltd | Use of hemicellulose microparticles as vaccine adjuvant |
| CN106573057A (zh) * | 2014-08-04 | 2017-04-19 | 日东电工株式会社 | 含有血栓症治疗药的体液免疫诱导促进组合物及疫苗药物组合物 |
-
1971
- 1971-03-02 DE DE19712110488 patent/DE2110488A1/de active Pending
-
1972
- 1972-02-24 ZA ZA721224A patent/ZA721224B/xx unknown
- 1972-02-25 ES ES400162A patent/ES400162A1/es not_active Expired
- 1972-02-29 IL IL38861A patent/IL38861A0/xx unknown
- 1972-03-01 FR FR7207042A patent/FR2128467A1/fr active Granted
- 1972-03-02 NL NL7202806A patent/NL7202806A/xx unknown
- 1972-03-02 AT AT174972A patent/AT312801B/de not_active IP Right Cessation
- 1972-03-02 BE BE780131A patent/BE780131A/xx unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995002688A1 (en) * | 1993-07-16 | 1995-01-26 | Chiron Viagene, Inc. | Methods and compositions for the removal of viruses and uses thereof |
| WO2001049320A3 (en) * | 2000-01-05 | 2002-01-17 | Cambridge Biopolymers Ltd | Use of hemicellulose microparticles as vaccine adjuvant |
| CN106573057A (zh) * | 2014-08-04 | 2017-04-19 | 日东电工株式会社 | 含有血栓症治疗药的体液免疫诱导促进组合物及疫苗药物组合物 |
| EP3178495A4 (en) * | 2014-08-04 | 2018-01-17 | Nitto Denko Corporation | Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug |
| US10456464B2 (en) | 2014-08-04 | 2019-10-29 | Nitto Denko Corporation | Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug |
| CN106573057B (zh) * | 2014-08-04 | 2021-01-08 | 日东电工株式会社 | 含有血栓症治疗药的体液免疫诱导促进组合物及疫苗药物组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| AT312801B (de) | 1974-01-25 |
| FR2128467B1 (enExample) | 1975-02-07 |
| DE2110488A1 (de) | 1972-09-07 |
| ES400162A1 (es) | 1974-12-16 |
| NL7202806A (enExample) | 1972-09-05 |
| BE780131A (fr) | 1972-09-04 |
| IL38861A0 (en) | 1972-04-27 |
| ZA721224B (en) | 1972-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lindsay et al. | Toxic Properties of a Synthetic Double-stranded RNA: Pyrogenicity of Poly I. Poly C in Rabbits | |
| Feldmann et al. | The requirement of macrophages in the secondary immune response to antigens of small and large size in vitro | |
| IE37187L (en) | Immunological adjunants for vaccines | |
| Forget et al. | Antigenic specificities of bursal and thymic lymphocytes in the chicken | |
| Weinstein et al. | Effect of types of treatment on development of antistreptolysin in patients with scarlet fever. | |
| US3991182A (en) | Transfer factor | |
| Levy-Koenig et al. | Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody | |
| FR2128467A1 (en) | Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen | |
| IT967048B (it) | Copolimeri alternati di etilene alchil acrilati e monomeri con centri di vulcanizzazione e pro cesso per la loro preparazione | |
| ES2040239T3 (es) | Procedimiento de preparacion de una composicion farmaceutica para la profilaxis y terapia de la ulcera gastrica. | |
| ES2055314T3 (es) | Tratamiento de disfuncion leucocitaria con gm-csf. | |
| Vandeputte et al. | Influence and production of interferon in Rauscher virus infected mice | |
| Sokal et al. | Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules | |
| NL930117I1 (nl) | Samenstelling voor verbeterde adsorptie van verschillende kationen | |
| IL40123A (en) | 2-amino-4-phenyl-2-imidazolines and pharmaceutically acceptable acid addition salts thereof and methods for their preparation | |
| Moya et al. | Immunomodulatory activity of isoprinosine on experimental viral infections in avian models | |
| Bocanegra et al. | Convalescent burn plasma therapy for severely burned children. Control study of 81 cases and tests for Pseudomonas antibodies | |
| Dobbs et al. | Enhancement of antibody production after treatment with actinomycin-D: interrelationships between 7S and 19S antibody | |
| FR2287912A1 (fr) | Derives de polysaccharide portant des groupements amines, leurs procedes de preparation et leurs applications en tant qu'agents adjuvants de l'immunite non specifique | |
| ES482549A0 (es) | Un metodo para la preparacion de una composicion de virus herpes | |
| GB665405A (en) | Improvements in contractable bands for securing glass and other closures to the mouths of reflectors and kindred articles | |
| USD188335S (en) | Beaded toy train | |
| 贾万钧 | MODEL OF ANTIGEN-ANTIBODY REACTION AND ITS OPTIMAL PROPORTION IN EQUIVALENT ZONE | |
| Lutsik | The treatment of meningococcemia by preserving immune homeostasis | |
| Dolan et al. | Hypogammaglobulinemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |